News Early Clovis approval notches up competition in ovarian canc... Clovis' Rubraca will compete against AstraZeneca rival.
News Success for ex-Pfizer scientists with Novartis dermatology s... Novartis is to acquire Ziarco, a privately held UK company focused on developing new treatments in dermatology.
Views & Analysis Digital health round-up: can Xcertia clear the health app co... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Novartis Strong phase 3 data boosts Novartis' Ibrance rival Ribociclib will compete against Pfizer's breast cancer blockbuster
News Pfizer fined £84m for exploiting epilepsy drug price Pfizer hiked price by 2600%, says competition watchdog.
News BeyondSpring plans three-pronged attack on cancer The CEO of BeyondSpring said the company hopes to make its name with a new lung cancer drug and an innovative R&D strategy.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
